Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apogee Therapeutics, Inc. | Chief Medical Officer | Common Stock | 255K | $12.2M | $47.92 | Jan 2, 2025 | Direct |
Apogee Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 172K | Jan 2, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APGE | Apogee Therapeutics, Inc. | Jan 2, 2025 | 5 | -$161K | 4 | Jan 3, 2025 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Dec 11, 2024 | 4 | -$180K | 4 | Dec 13, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Dec 9, 2024 | 1 | $0 | 4 | Dec 11, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Dec 4, 2024 | 1 | -$307K | 4 | Dec 6, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Nov 6, 2024 | 2 | -$394K | 4 | Nov 8, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Oct 2, 2024 | 2 | -$375K | 4 | Oct 4, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Sep 4, 2024 | 2 | -$317K | 4 | Sep 6, 2024 | Chief Medical Officer |
ORKA | Oruka Therapeutics, Inc. | Aug 29, 2024 | 0 | $0 | 3 | Sep 6, 2024 | Director |
APGE | Apogee Therapeutics, Inc. | Aug 7, 2024 | 3 | -$298K | 4 | Aug 9, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Jul 3, 2024 | 2 | -$225K | 4 | Jul 5, 2024 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Dec 18, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Chief Medical Officer |
APGE | Apogee Therapeutics, Inc. | Jul 13, 2023 | 0 | $0 | 3/A | Jul 17, 2023 | Chief Medical Officer |